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Abstract
The COVID-19 pandemic, instigated by the SARS-CoV-2 coronavirus, continues to plague the globe.
The SARS-CoV-2 main protease, or Mpro, is a promising target for development of novel antiviral
therapeutics. Previous X-ray crystal structures of Mpro were obtained at cryogenic temperature or room
temperature only. Here we report a series of high-resolution crystal structures of unliganded Mpro
across multiple temperatures from cryogenic to physiological, and another at high humidity. We
interrogate these datasets with parsimonious multiconformer models, multi-copy ensemble models,
and isomorphous difference density maps. Our analysis reveals a temperature-dependent
conformational landscape for Mpro, including mobile solvent interleaved between the catalytic dyad,
mercurial conformational heterogeneity in a key substrate-binding loop, and a far-reaching
intramolecular network bridging the active site and dimer interface. Our results may inspire new
strategies for antiviral drug development to counter-punch COVID-19 and combat future coronavirus
pandemics.

Synopsis
X-ray crystallography at variable temperature for SARS-CoV-2 Mpro reveals a complex conformational
landscape, including mobile solvent at the catalytic dyad, mercurial conformational heterogeneity in a
key substrate-binding loop, and an intramolecular network bridging the active site and dimer interface.

Keywords
protein structure, protein flexibility, X-ray crystallography, allostery, solvent
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Introduction
COVID-19 is a global pandemic disease caused by severe acute respiratory syndrome coronavirus 2.
SARS-CoV-2 is a highly infectious, airborne, respiratory virus, which has caused over 200 million
infections and nearly 5 million deaths worldwide as of October 2021. Over the the past year and a
half, several approaches to prevent and treat COVID-19 have been successfully developed, including
new vaccines, monoclonal antibody treatments (Baum et al., 2020), and repurposed existing
therapeutics (Beigel et al., 2020; Boras et al., 2021). However, development of novel small-molecule
antiviral drugs has lagged behind. New antiviral drugs would not only provide a powerful weapon
against COVID-19 for infected patients and frontline workers, but would also aid in preparation for
future coronavirus pandemics.

A promising target for potential new antiviral drugs against SARS-CoV-2 is a chymotrypsin-like
protease known by several names: non-structural protein 5, nsp5, 3C-like protease, 3CLpro, main
protease, or Mpro. Mpro is part of a polyprotein encoded by the viral RNA genome. After being excised
from the polyprotein by its own proteolytic activity, Mpro cleaves at no fewer than 11 sites in the
polyprotein to generate individual functional proteins (V’kovski et al., 2021) that help the virus
replicate. Due to its importance to the SARS-CoV-2 life cycle, Mpro has been identified as a key target
for COVID-19 drug design.

Drug design efforts focused on Mpro have been aided by insights from structural biology. The first
SARS-CoV-2 Mpro crystal structures were released in the Protein Data Bank (PDB) (Berman et al.,
2000) early in the pandemic, within the first week of February 2020 (Jin et al., 2020). These structures
revealed that, like SARS-CoV Mpro before it, SARS-CoV-2 Mpro is composed of two β-barrel domains
known as domain I and domain II, and an α-helical bundle known as domain III (Fig. 1a). The active
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site cavity is located on the surface, with the His41–Cys145 catalytic dyad positioned between domain
I and domain II. Domain III is involved in regulating dimerization (Zhang et al., 2020), which is critical
for coronavirus Mpro catalytic activity (Fan et al., 2004; Goyal & Goyal, 2020). Since the initial
structures of SARS-CoV-2 Mpro, X-ray crystallography has been used to identify promising ligand
binding sites and alternate structural states of the protein, resulting in a total of over 250 available
structures. These efforts included co-crystallography with an eye toward drug repurposing (Vuong et
al., 2020; Günther et al., 2021), as well as crystallographic screens of non-covalent and covalent
small-molecule fragments to establish new toe-holds for ab initio drug design (Douangamath et al.,
2020) which were then leveraged via a crowd-sourced process to design novel inhibitors (Chodera et
al., 2020).

As with much modern protein crystallography, the above experiments were performed at cryogenic
temperatures, which can bias protein conformational ensembles (Fraser et al., 2011; Keedy et al.,
2014). To bypass this limitation, a room-temperature crystal structure of unliganded Mpro was reported
(Kneller, Phillips, O’Neill, Jedrzejczak et al., 2020) (PDB ID 6WQF). Although its resolution was only
moderate (2.3 Å), it nevertheless revealed evidence of conformational plasticity near the active site
that was distinct relative to past cryogenic structures. Subsequent work built on this foundation of
room-temperature crystallography to dissect Mpro function (Kneller, Phillips, Kovalevsky et al., 2020;
Kneller, Phillips, O’Neill, Tan et al., 2020). However, no studies to date have reported crystal structures
of Mpro across a wide range of temperatures. Previously, such a multitemperature crystallography
strategy was instrumental for revealing novel aspects of correlated active-site conformational
heterogeneity in a dynamic proline isomerase (Keedy et al., 2015) and of long-range allosteric
signaling in a therapeutic-target tyrosine phosphatase (Keedy et al., 2018).
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Here we report high-resolution crystal structures of SARS-CoV-2 Mpro at five temperatures: 100 K
(cryogenic), 240 K (above the so-called glass transition or dynamical transition (Keedy et al., 2015)),
277 K (“room temperature” in many crystallography studies), 298 K (ambient), and 310 K
(physiological). We also report a structure at ambient temperature but high relative humidity (99.5%
RH) to gauge the relative effects of temperature vs. humidity on Mpro. To our knowledge, this study
represents the first experimentally based structural analysis for any SARS-CoV-2 protein at variable
temperature and/or humidity. We used careful data collection with a helical strategy to minimize
radiation damage, thereby isolating the effects of temperature and humidity on Mpro. For all datasets
we have constructed parsimonious multiconformer models as well as multi-copy crystallographic
ensemble models, which provide complementary insights into protein structural flexibility as a function
of temperature and humidity. Together, our data reveal a network of subtle but provocative
temperature-dependent conformational heterogeneity, not only at the catalytic site but also spanning
several functionally relevant sites throughout Mpro, which may help motivate an allosteric strategy for
antiviral drug design to combat COVID-19 and/or future coronavirus pandemics.

Results
Multitemperature crystallographic data collection and modeling
Data were obtained from single Mpro crystals using helical data collection, to maximize diffraction
intensity while minimizing radiation damage (Supp. Fig. 1). To probe the conformational landscape of
Mpro, we obtained high-resolution structures at five different temperatures: 100 K, 240 K, 277 K, 298 K
(ambient; see Methods), and 310 K. Our datasets thus span a broad temperature range: cryogenic,
just above the glass transition or dynamic transition (Keedy et al., 2015), the range often noted as
room temperature (roughly 293–300 K), and approximately physiological temperature. We also
collected another 298 K dataset with high relative humidity (99.5% RH).
5
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For all but the 277 K dataset (2.19 Å), the resolution was 2 Å or better (Table 1). The highest
resolution was for the 100 K dataset (1.55 Å). Even at the higher temperatures, we saw little to no
evidence of radiation damage (Supp. Fig. 1). After data reduction, we created a multiconformer model
for each temperature, which includes a single conformer for most portions of the structure but
alternate conformations where appropriate (Riley et al., 2021). See Methods for more details on data
collection and modeling, and Table 1 for overall diffraction data and refinement statistics.

Structure

100 K

240 K

277 K

298 K

298 K,
99.5% RH

310 K

PDB ID

7MHF

7MHG

7MHH

7MHI

7MHJ

7MHK

Resolution (Å)

48.07–1.55 55.62–1.53 48.96–2.19 56.29–1.88 56.30–2.00 43.97–1.96

Completeness
(%)

99.7 (96.0) 100 (99.4)

99.9 (98.7) 100 (100)

99.0 (97.4) 99.9 (100)

Multiplicity

3.4 (3.4)

6.6 (6.2)

6.9 (6.9)

6.8 (6.9)

6.8 (6.7)

6.6 (6.7)

I/sigma(I)

3.3 (1.0)

7.9 (0.9)

4.5 (1.1)

5.0 (0.4)

6.3 (0.6)

5.4 (0.3)

Rmerge(I)

0.158
(0.507)

0.180
(1.463)

0.292
(1.805)

0.182
(2.353)

0.178
(1.708)

0.195
(1.805)

Rmeas(I)

0.188
(0.604)

1.960
(1.600)

0.316
(1.954)

0.197
(2.548)

0.193
(1.854)

0.213
(1.957)

Rpim(I)

0.100
(0.325)

0.076
(0.639)

0.119
(0.742)

0.076
(0.967)

0.074
(0.711)

0.084
(1.046)

CC1/2

0.977
(0.695)

0.995
(0.356)

0.985
(0.799)

0.990
(0.285)

0.989
(0.376)

0.990
(0.352)

Wilson B-factor

16.164

16.370

31.769

29.670

34.350

33.810

Total
observations

127548

263470

97820

152368

125878

128140

Unique
observations

37901

39975

14120

22459

18588

19444

Space group

C121

C121

C121

C121

C121

C121
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Unit cell
dimensions
(Å,Å,Å,°,°,°)

113.71,
53.32,
44.57, 90,
102.96, 90

114.19,
53.49,
45.00, 90,
103.04, 90

115.02,
54.36,
44.97, 90,
101.50, 90

114.74,
54.57,
45.11, 90,
101.65, 90

114.88,
54.74,
45.24, 90,
101.42, 90

114.3,
54.29,
44.97, 90,
102.12, 90

Solvent content
(%)

35.88

36.40

38.95

39.53

39.89

38.36

Rwork

0.1834

0.1701

0.1994

0.1847

0.1942

0.2039

Rfree

0.2223

0.2043

0.2547

0.2276

0.2421

0.2482

RMS bonds (Å)

0.006

0.011

0.002

0.003

0.004

0.003

RMS angles (°)

0.888

1.094

0.472

0.569

0.702

0.576

Ramachandran
outliers (%)

0.33

0.33

0.33

0.00

0.33

0.66

Ramachandran
favoured (%)

97.70

98.36

96.71

97.37

96.38

97.37

Clashscore

3.81

2.42

2.31

1.89

2.31

2.73

MolProbity score

1.24

1.02

1.22

1.07

1.25

1.18

Table 1: Crystallographic statistics for multitemperature datasets and multiconformer models. Overall
statistics given first (statistics for highest-resolution bin in parentheses). RH = relative humidity. RMS =
root-mean-square deviation from ideal values. For Phenix ensemble model refinement statistics, see Table 2.

Overall structure as a function of temperature
The global structure of Mpro in our crystals remains similar across temperatures (Fig. 1d, Supp. Fig.
2), as expected. Indeed, the maximum Cα RMSD between any pair of structures in the
ambient-humidity multitemperature series is only 0.64 Å, and the maximum all-atom RMSD is only
0.98 Å. However, there is a clear clustering between lower-temperature (240, 277 K) and
higher-temperature (277, 298, 310 K) structures, based on either Cα RMSD (Fig. 1d) or all-atom
RMSD (Supp. Fig. 2). These observations indicate that aspects of the Mpro conformational landscape
change in response to temperature.

Humidity also appears to have some effect on Mpro structure, as evidenced by the fact that the overall
largest pairwise Cα RMSD (0.65 Å, Fig. 1d) and all-atom RMSD (1.04 Å, Supp. Fig. 2) involve the
7
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298 K high-humidity (99.5% RH) structure. However, the corresponding RMSD values for the 298 K
ambient-humidity (36.7% RH) structure are only slightly smaller (<0.1 Å difference). These RMSD
differences between high vs. low humidity are minor compared to the differences between the high vs.
low temperature clusters mentioned above. Thus, temperature affects Mpro structure noticeably more
than does humidity. This result contrasts with previous studies of lysozyme in which similar protein
structural alterations were achieved by either small changes in humidity or large changes in
temperature (Atakisi et al., 2018); this discrepancy may result from different protein:solvent
arrangements in the lysozyme vs. Mpro crystal lattices.
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Figure 1: Overall structure of SARS-CoV-2 main protease at multiple temperatures.
a. New X-ray crystal structure of apo Mpro at physiological temperature (310 K) (red). The biological dimer
involving the other monomer (light grey surface) is constituted via crystal symmetry. The competitive inhibitor N3
from a previous structure (PDB ID 6LU7) (semi-transparent, dark grey surface) is shown in both protomers for
context.
b. Close-up view of the Mpro active site region, including the catalytic dyad of Cys145 and His41 (red sticks) and
highlighting residues that form the substrate binding pocket (yellow surface).
c. Cartoon putty representation of conformational variability between new Mpro structures described in this work:
100 K, 240 K, 277 K, 298 K, 298 K (99.5% RH), and 310 K. Thickness and color indicate root-mean-square
fluctuations (RMSF) of Cα atom positions, from low (thin, dark blue) to high (thick, yellow). The largest
differences between these structures’ backbones occur between residues 192–198. Same view as a. See also
Supp. Fig. 3.
d. Heatmap of pairwise Cα atom root-mean-square deviation (RMSD) between final refined structures, revealing
temperature-dependent clustering (top-right vs. bottom-left). See also Supp. Fig. 2.
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Temperature dependence of local alternate conformations
To provide more detailed insights into the observed global temperature dependence, we sought to
identify alternate conformations at the local scale that were stabilized or modulated by the
temperature shifts in our experiments. We specifically focused our attention on areas of the protein
that are of interest for drug design and/or biological function: the active site, nearby loops associated
with substrate binding, and the dimer interface.

Figure 2: The unliganded Mpro active site as a function of temperature and humidity.
2Fo-Fc electron density (1.0 σ, gray mesh) and interatomic distances (pink, in Å) shows that the active-site
structure remains similar across datasets, including the catalytic dyad of His41 and Cys145 and the presumed
catalytic water (H2Ocat). One minor exception is a different water, H2Oint, which tends to shift upward in this view
as temperature increases, adjusting its interactions with His41 and Cys145 (see also Fig. 3). An ordered DMSO
molecule from the crystallization solution is visible at the left of each panel, except for 298 K at high humidity
(99.5% RH) in which case a water is present at the same site instead.
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First, the Mpro active site structure remains mostly consistent across our temperature series (Fig. 2).
The catalytic amino acids are in very similar conformations across temperatures. Additionally, a key
active-site water molecule (known as H2Ocat), which hydrogen-bonds to both of the side chains of the
catalytic dyad (His41 and Asp187), remains in the same position across our structures (Fig. 2). It has
been suggested (Kneller, Phillips, O’Neill, Jedrzejczak et al., 2020) that this water may play the role of
a third catalytic residue (in addition to the catalytic dyad of His41 and Cys145). As previously noted
(Kneller, Phillips, O’Neill, Jedrzejczak et al., 2020), H2Ocat is not modeled in some cryogenic structures
— but it is modeled in 89% (224/252) of the publicly available structures of SARS-CoV-2 Mpro as of
Oct. 11, 2021 (the vast majority of which are cryogenic), and perhaps should have been modeled in
others (Jaskolski et al., 2021).

As with the active-site amino acids and H2Ocat, a dimethyl sulfoxide (DMSO) molecule from the
crystallization solution is ordered nearby in each structure in the multitemperature series (Fig. 2, left of
each panel). Interestingly, however, this DMSO is displaced by a water molecule in the high-humidity
dataset (298 K, 99.5% RH), suggesting that the solvation distribution of the Mpro active site is
malleable. Similarly, another DMSO in a distal region of the protein is ordered throughout the
multitemperature series, but two waters and a new side-chain rotamer for Arg298 displace it in the
high-humidity dataset.

Another putative active-site water, which we refer to as the “intervening water” or H2Oint, is also present
in each of our structures. However, unlike H2Ocat, H2Oint is modeled in only <1% (2/252) of available
structures: 7K3T (the highest-resolution Mpro structure available; apo state; B.A., D.K., M.R.F., S.M. et
al., in preparation) and 7JFQ (“de-oxidized C145”, no publication). There are experimental differences
among the structures that do have H2Oint modeled, as well as amongst those that do not have it
modelled but do have electron density for it. For example, 7JFQ is in a different space group than our
11
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structures, with different crystallization conditions, including pH — so it is not immediately obvious
what causes this water to sometimes be visibly ordered. See Supp. Text 1 for a more thorough
discussion of H2Oint modeling.

Interestingly, in our temperature series, H2Oint is not static, but rather varies in position across
temperatures by nearly 1 Å (Fig. 3a), which is significantly in excess of the estimated coordinate error
of 0.18–0.34 Å for our structures (calculated using the Diffraction Precision Index online server
(Kumar et al., 2015)). Together with its absence in many other structures, this suggests that H2Oint is in
some sense mobile. There is a rough trend of higher temperatures corresponding to H2Oint positions
farther from the backbone of His41 and Cys145 and closer to His164, although this is not a strict rule.
At 298 K, H2Oint is in an almost identical position regardless of humidity (ambient or 99.5% RH),
suggesting both that environmental humidity has minimal effects on these crystals and again that our
structural results with respect to temperature dependence may be precise. Some positional
uncertainty may stem from the fact that the 2Fo-Fc electron density for this water is not fully discrete,
but rather appears semi-contiguous with the density for the adjacent catalytic His41 and Cys145 side
chains (at typical map σ levels; Fig. 2).

Although H2Oint is absent from the vast majority of the other hundreds of crystal structures of Mpro, it is
displaced or “mimicked” by ligands in some instances. For example, a Zn2+ ion from an ionophore
binds in the same position in PDB ID 7B83 (Günther et al., 2021) (Fig. 3b). In addition, Zn2+ alone was
bound in two other structures, including PDB ID 7DK1 (Panchariya et al., 2021). However, Zn2+ is not
consistent with our data (see Supp. Text 1). In addition, several covalent ligands that target the
catalytic Cys145 form thiohemiketal or thiohemiacetal adducts, where the hydroxyl group is placed
near His41 in a similar position as H2Oint in our structures (Sacco et al., 2020). (Fig. 3c). Interestingly,
the swath of positions for this hydroxyl group, including a more extreme position due to a distinct
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conformation of the linker (PDB ID 6XFN), aligns with the swath of positions taken by H2Oint across our
temperature series (plus PDB ID 7K3T and 7JFQ) (Fig. 3c). Together, these data suggest a structural
niche for H2Oint that, regardless of its potential role in the catalytic mechanism, may be productively
exploited for small-molecule ligand design.

Figure 3: The rare active-site intervening water (H2Oint) is sensitive to temperature and mimicked by
ligands.
a. In our new structures, H2Oint is ordered between Cys145 and His41 of the Mpro catalytic dyad, but its position
varies as a function of temperature (blue to red). 298* K = 298 K at 99.5% relative humidity. The position of
H2Oint in the 298 K model collected at 99.5% relative humidity occupies an extremely similar position as that of
H2Oint in the 298 K model (orange). In only 2/252 previous structures of SARS-CoV-2 Mpro (7K3T and 7JFQ, both
100 K) is H2Oint also ordered.
b-c. H2Oint is mimicked/displaced by particular atoms in other previous structures of Mpro. Together these
encompass the swath of H2Oint positions.
b. In 7B83, Zn2+ from zinc pyrithione (purple) displaces H2Oint.
c. In several structures from different series of covalent ligands (grey) linked to Cys145, a hydroxyl oxygen of
the covalent adduct displaces H2Oint. One of these thiohemiketals is observed in a distinct (R) conformation
(6XFN, lighter grey), which places the hydroxyl oxygen at a more extreme position corresponding to H2Oint in our
310 K structure. Together these binders approximate the swath of H2Oint positions in our multitemperature
series.

Beyond the active site, we turned our attention to the nearby P5 binding pocket, specifically the loop
composed of residues 192–198. Previously, the first report of a room-temperature structure of Mpro,
which was in the apo form (PDB ID 6WQF) (Kneller, Phillips, O’Neill, Jedrzejczak et al., 2020), noted
that this loop adopted a different conformation than in a prior 100 K apo structure (PDB ID 6Y2E)
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(Zhang et al., 2020), including rotated peptide orientations for Ala194–Gly195 and Asp197–Thr198.
However, all of the structures in our multitemperature series, including at lower temperatures (100 K
and 240 K), have a single backbone conformation in this region that matches that of 6WQF (Fig. 4a).
In addition, other apo cryogenic structures, including one at high (1.2 Å) resolution (PDB ID 7K3T),
also match the 6WQF backbone conformation. All of these structures (6WQF, 6Y2E, 7K3T, and our
multitemperature series) derive from the same crystal form (Table 1). Thus, it appears the different
loop conformation adopted in 6Y2E is not driven by temperature (Kneller, Phillips, O’Neill, Jedrzejczak
et al., 2020), nor by ligand binding or crystal lattice effects, but rather by some other aspect of the
crystallization details or sample handling conditions — including, perhaps, idiosyncratic effects of
crystal cryocooling (Halle, 2004; Keedy et al., 2014). Our conclusion here is also supported by a
recent retrospective analysis of existing structures (Jaskolski et al., 2021).
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Figure 4: Complex temperature dependence of residues 192–198 in the P5 binding pocket.
a. Mpro monomer from cryogenic structure, coloured by domain: domain I, residues 8–101, pale green; domain II,
residues 102–184, pale blue; domain III, residues 201–303, pale orange. Catalytic dyad residues Cys145 and
His41 are shown as sticks (red). Terminal residues are shown in dark grey. P5 binding pocket linker loop
(residues 190–200) shown in dark grey and as sticks (black box).
b. Our new multitemperature structures all have a single backbone conformation for this linker loop region.
Regardless of temperature, they all match a similar backbone conformation to the room-temperature 6WQF
model (yellow), and not the cryogenic 6Y2E model (grey) (Kneller, Phillips, O’Neill, Jedrzejczak et al., 2020).
(298* K = 298 K, 99.5% relative humidity.)
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c-e. Phenix ensemble refinement models based on our multitemperature datasets reveal a complex pattern of
flexibility that was “hidden” in b.
c. For some conditions (100 K, blue; 240 K, cyan; 310 K, red; 298* K, magenta), the ensemble models generally
match 6WQF, albeit with variability around the average conformation. For the Ala194–Gly195 peptide (pink
arrow), all four conditions match 6WQF. For the Asp197–Thr198 peptide (black arrow), 100 K, 240 K, and 310 K
match 6WQF, whereas 298* K adopts a swath of orientations at the Asp197–Thr198 peptide, bridging 6WQF
and 6Y2E.
d. For other conditions (277 K, green; 298 K, orange), the ensemble models exhibit shifts away from 6WQF and
toward 6Y2E. For the Ala194–Gly195 peptide, both conditions match 6Y2E (pink arrow) instead of 6WQF. For
the Asp197–Thr198 peptide, both conditions adopt a swath of orientations (black curved arrow) bridging 6WQF
and 6Y2E, similarly to 298* K (in c).
e. A zoomed-in and ~80° rotated view of the 310 K ensemble model illustrates a split between the primary
conformation and a distinct alternate conformation, centered on Ala193 (red arrows). This split is unique to the
310 K ensemble model.

Crystallographic ensemble models reveal distinct backbone conformational
heterogeneity
We next aimed to complement this analysis of our manually built multiconformer models with a more
automated and explicitly unbiased approach to modeling flexibility that can handle larger-scale
backbone flexibility such as loop motions. Therefore, we turned to Phenix ensemble refinement, which
uses molecular dynamics simulations with time-averaged restraints to crystallographic data (Burnley
et al., 2012). Phenix ensemble models have been used fruitfully for many applications (Woldeyes et
al., 2014), including exploring the effects of temperature on protein crystals (Keedy et al., 2014),
assessing the conformational plasticity of peptide–MHC interactions (Fodor et al., 2018), and rational
protein design (Broom et al., 2020). After a scan of parameter space (see Methods), we created one
ensemble model per temperature, each of which contains 18 to 45 constituent models (Table 2).
Compared to the multiconformer models, the ensemble models fit the experimental data equally well
or better based on Rfree, albeit with slightly wider Rfree-Rwork gaps (Table 2 vs. Table 1).

Structure

100 K

240 K

277 K

298 K

298 K,
99.5% RH

310 K

PDB ID

7MHL

7MHM

7MHN

7MHO

7MHP

7MHQ
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Resolution (Å)

1.55

1.53

2.19

1.88

2.00

1.96

pTLS

1

1

1

1

1

1

wx-ray

2.5

2.5

2.5

2.5

2.5

2.5

# models in
ensemble

45

43

18

20

36

42

Rwork

0.1700

0.1606

0.1626

0.1667

0.1592

0.1686

Rfree

0.2235

0.1978

0.2169

0.2077

0.2174

0.2240

Table 2: Refinement statistics for Phenix ensemble models. pTLS and wx-ray are input parameters to Phenix
ensemble refinement; the other input parameter (τx) was automatically determined (see Methods).

Using these ensemble models, we reexamined the P5 binding pocket loop mentioned above. The
100, 240, and 310 K ensemble models are similar to the previous “room-temperature” structure
6WQF, with mostly the same peptide orientation for Ala194–Gly195 and Asp197–Thr198 ( Fig. 4c). By
contrast, the 277 and 298 K ensemble models match the flipped Ala194–Gly195 peptide orientation
from the previous cryogenic structure 6Y2E, and sample a swath of conformations for Asp197–Thr198
that span 6WQF and 6Y2E (Fig. 4d). Interestingly, although the 298 K 99.5% RH model follows a
similar Ala194–Gly195 peptide orientation to 100, 240 and 310 K, it also exhibits a swath of peptide
conformations for Asp197–Thr198, similar to our 277 and 298 K ensemble models. The distinction
between ensembles that match 6WQF vs. 6Y2E is not simply a byproduct of resolution: although 277
K has the lowest resolution (2.19 Å), 298 K (1.88 Å) has a better resolution than 310 K (1.96 Å).
Further, our 310 K ensemble reveals a distinct conformational split in this loop region, centered on
Ala193, indicated by a subset of models within the ensemble following the primary conformation and a
second subset following a separate, different conformation (Fig. 4e). Taken together, these results
suggest that this region may have complex temperature dependence, as well as the capacity to
sample alternate conformations that are “captured” in particular individual structures.
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Figure 5: Backbone structural variability of ensemble models along the Mpro sequence as a function of
temperature.
a. Root-mean-square fluctuation (RMSF) of Cα backbone atom positions is plotted vs. residue number for each
of the different structures in our multitemperature series (colors in legend). RMSF spikes at the N-terminus,
C-terminus, and β-turn 153–157 (in contact with the C-terminus) in the ensemble models are truncated in this
plot, and should be interpreted with caution.
b-f. Backbone structures from ensemble refinement are shown for regions coinciding with
temperature-dependent RMSF peaks. The refined single structure is shown as a cartoon, while atoms in the
backbone of ensemble models are shown as lines.
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Beyond just the P5 loop, we also examined other regions with elevated and/or temperature-dependent
ensemble Cα root-mean-square fluctuation (RMSF) (Fig. 5a) that were not previously noted as being
temperature-dependent. These regions segregate into different categories with distinct temperature
dependence.

First, some regions display a generally positive correlation between backbone structural variability and
diffraction experiment temperature. For example, residues 218–227 (Fig. 5e) and 273–278 (Fig. 5f)
are highly ordered at 100 K and 240 K, but mobile at warmer temperatures. These regions are
spatially contiguous in the monomer, within the helical domain III. In another case, residues 68–76
(Fig. 5c), conformational diversity is restricted to the β-hairpin at 100 K and 240 K, but appears to
spread further down the β-strands at higher temperatures. Interestingly, although 68–76 is isolated
from the regions described earlier (218–227 & 273–278) in the monomer and the biologically-relevant
dimer, it is contiguous with them in the crystal lattice. In contrast to these regions with
quasi-continuous temperature dependence, we observe a more abrupt response for residues
103–108 (Fig. 5d), which shows significant backbone heterogeneity only at 310 K. Notably, this region
is spatially separated (within the monomer, dimer, and lattice) from the regions mentioned above that
have a less abrupt temperature response. Finally, we observe one region with an atypical relation
between backbone variability and temperature: the short 310 helix at residues 46–51 (Fig. 5b). This
region abuts the P5 substrate binding loop composed of residues 192–198 with its complex
temperature dependence (Fig. 4); together, these two regions form one side of the active site pocket
(Fig. 1b).
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A network of coupled conformational heterogeneity bridges the active site,
substrate pocket, inter-domain interface, and dimer interface
To complement the model-centric approaches above, we also looked for temperature-dependent
conformational effects using an approach that is more directly data-driven: isomorphous Fo-Fo
difference electron density maps. We computed Fo-Fo difference maps for each temperature vs. 100
K, and looked for patterns in terms of spatial colocalization of difference peaks. The global results
confirm that the protein structure remains similar overall, with a smattering of difference peaks
throughout the monomer asymmetric unit (Supp. Fig. 4). However, within those difference peaks lies
a provocative stretch of difference features spanning the dimer interface, the interface between
domain I and domain II of the monomer, and the edge of the P5 substrate binding pocket (Fig. 6).
These difference features may be somewhat resolution-dependent, as they are least pronounced for
277 K (2.19 Å) and most pronounced for 240 K (1.53 Å), but their distribution across Mpro is
qualitatively similar across temperatures.

A closer examination of the models in the vicinity of these difference features reveals what appears to
be a series of correlated conformational motions keyed to temperature change. For example, Fo-Fo
density shows that Glu290 shifts from a single side-chain rotamer at 100 K to two alternate rotamers
with partial occupancies at 240 K (Fig. 6a); this second rotamer seen at 240 K then remains as a
single full-occupancy conformation for all higher temperatures. In sync with Glu290, our
multiconformer models show that the adjacent Cys128 shifts its conformational distribution, but in the
opposite fashion: from two alternate rotamers to one (Fig. 6a). Both Glu290 and Cys128 interact with
a symmetry-related Arg4 across the biological dimer interface (Fig. 6b). Interestingly, two
small-molecule fragments from recent crystallographic screens (Douangamath et al., 2020; Noske et
al., 2021) bind at this area of the dimer interface (Fig. 6a-b). Moreover, ordered polyethylene glycol
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(PEG) molecules from several previous structures illustrate the potential for future ligand design
efforts to “grow” from one of these initial fragment hits (5RF0) toward the mobile Glu290 and Cys128.
This observation reinforces the idea that molecules from crystallization solutions, such as glycols, can
reveal useful features like cryptic binding pockets (Bansia et al., 2021).

Glu290 is connected to another interesting residue, Asp197, via a hydrogen-bond network with only
one intervening side chain (Arg131). Within this vicinity, an interacting water molecule is liberated, and
an adjacent residue, Thr198, shifts from two alternate side-chain rotamers to just one (Fig. 6c). The
Thr198 motion is linked to a conformational change for the nearby Glu240 side chain and Pro241
backbone, thus establishing a possible means for allosteric communication across the inter-domain
interface. In the opposite direction from Asp197, other adjacent residues experience changes in
ordering per Fo-Fo peaks; these residues together form the 192–198 loop of the functionally important
and mobile P5 pocket (Fig. 4) leading toward the active site.

Overall, these observations describe a series of conformational motions that bridge the dimer
interface, inter-domain interface, substrate binding pocket, and active site (Fig. 6 center, boxes and
oval). In this work, temperature is the perturbation/effector — but our results raise the enticing
possibility that future small molecules could be used to allosterically perturb this network, thereby
modulating enzyme dimerization and/or catalysis.
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Figure 6: Fo-Fo difference maps reveal local conformational shifts connecting the active site,
inter-domain interface, and dimer interface.
Center: Overview of isomorphous Fo-Fo difference electron density map at +/-3 σ (green/red mesh) for the 240 K
dataset (cyan) minus the 100 K dataset (dark blue). (See Supp. Fig. 4 for Fo-Fo maps for all temperatures).
Ligands from cocrystal structures are shown at the active site (dashed oval) (pale orange, 6LU7), inter-domain
interface (purple, 5REE; yellow, 5REC), and dimer interface (orange, 7LFP; pink, 5FR0).
a. Glu290 switches from one side-chain rotamer at 100 K to two alternate rotamers at 240 K (curved arrow).
Glu290 is spatially adjacent to Cys128, which switches from two alternate rotamers at 100 K to a single rotamer
at 240 K in our multiconformer models. These residues are near two ligands from separate crystallographic
screens (7LFP, 5RF0), as well as many ordered PEG molecules from the crystallization cocktails of various
structures (7KVR, 7KVL, 7KFI, 7LFE).
b. A ~45° rotated view relative to a. shows that these two ligands bind at the dimer interface of the biological
monomer, constituted in the crystal from a symmetry-related protomer (grey surface). This interface also
includes the Asp197 region (right).
c. Thr198 switches from two alternate side-chain rotamers at 100 K to a single rotamer at 240 K, while Glu240
— located across the inter-domain interface — changes side-chain rotamer (curved arrows), with additional
effects on the adjacent backbone of Pro241. In the other direction from Asp197 (down in this view), other
residues in the P5 substrate binding pocket loop (Fig. 4) undergo conformational adjustments en route to the
active site. Meanwhile, an interacting water molecule at 100 K (blue sphere) becomes less ordered or displaced
at 240 K.
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Discussion
Our crystal structures of unliganded SARS-CoV-2 Mpro at variable temperature and humidity paint a
picture of a complex protein conformational landscape. The structure of Mpro does not change linearly
with temperature; rather, there is a global transition between roughly <240 K and >277 K (Fig. 1d,
Supp. Fig. 2). This 240–277 K transition regime for Mpro does not coincide with the 180–220 K glass
transition or dynamical transition threshold seen previously for other systems such as CypA (Keedy et
al., 2015), suggesting protein-to-protein variability. More locally in Mpro, as temperature increases,
different regions experience distinct types of changes to conformational heterogeneity (Fig. 5), in line
with previous multitemperature studies of other proteins (Keedy et al., 2014). These effects are not
limited to surface-exposed side chains as one might naïvely expect, but rather encompass motions of
buried side chains (Fig. 6), many backbone regions (Fig. 4, Fig. 5), and water molecules themselves
(Fig. 2, Fig. 3). Our results here for Mpro, as well as a large body of previous literature for other
systems, refute the assertion that X-ray crystallography under “unusual experimental conditions” like
variable temperature is not useful for understanding proteins (Jaskolski et al., 2021). By contrast, our
work is in line with computational analyses of B-factors suggesting that different alternate
conformations for Mpro (and other systems) can be accessed by varying temperatures and/or the
crystal lattice (Pearce & Gros, 2021).

A key example of temperature-sensitive, protein-associated solvent is the mobile water H2Oint that we
observe in the Mpro active site (Fig. 2, Fig. 3) (see Supp. Text 1). This rarely observed water’s
intriguing placement, with multiple permitted positions along a swath between the catalytic dyad of
His41 and Cys145, suggests it may play some role in the catalytic process (Lee et al., 2020). Notably,
recent structures of an acyl-enzyme intermediate structure (PDB ID 7KHP) and a C145A mutant
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product-bound structure (7JOY) of Mpro include a nearby water, ~1.5 Å away but aligned with our
approximately collinear multitemperature H2Oint swath (Fig. 3), which the authors suggested may play
a role as a deacylating nucleophile (Lee et al., 2020). Questions about the functional role of H2Oint
could be explored in parallel with other experiments to probe details of the catalytic mechanism, such
as variable pH to probe Cys145 oxidation and reactivity (Kneller, Phillips, O’Neill, Tan et al., 2020) and
neutron crystallography to reveal a zwitterionic state of the catalytic dyad (Kneller, Phillips, Weiss et
al., 2020), although questions remain about the interpretation of such data (Jaskolski et al., 2021).

Perhaps surprisingly, unlike temperature, high relative humidity during data collection does not affect
H2Oint in our structures (Fig. 2, Fig. 3). However, humidity does alter the solvation shell elsewhere
nearby in the active site (Fig. 2, bottom right). Displaceable waters could potentially be exploited to
design high-affinity small-molecule inhibitors, particularly when guided by water thermodynamics
maps from simulations, as are available for Mpro and other SARS-CoV-2 proteins (Olson et al., 2020).
More broadly, this result hints at the utility of humidity as an experimental variable in crystallography
(Kiefersauer et al., 2000; Sanchez-Weatherby et al., 2009) for exploring solvent slaving to solvent
energetics in ligand binding (Darby et al., 2019), protein dynamics (Lewandowski et al., 2015), and
other functionally relevant phenomena.

Phenix ensemble models (Burnley et al., 2012) refined from our X-ray datasets helped us to illuminate
temperature-dependent differences in conformational heterogeneity in certain areas of Mpro (Fig. 4,
Fig. 5) that were concealed by more traditional model types (Babcock et al., 2018). Despite its utility in
this and other work, there is significant potential for improvement of the ensemble refinement
methodology through, for example, integration of more sophisticated molecular mechanics force fields
like Amber (Moriarty et al., 2020) into the molecular dynamics component (Burnley et al., 2012) to
improve ensemble model geometry, or more sophisticated treatments of translation-libration-screw
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(TLS) groups to isolate interesting local conformational heterogeneity (Ploscariu et al., 2021).
Although it was also beyond the scope of this study, ensemble models may reveal alternate
conformational substates that are important for the catalytic cycle, which could be fruitfully targeted by
small molecules for antiviral drug design.

Finally, our results emphasize the allure of allosteric inhibition of Mpro as an alternative therapeutic
strategy. Our structures illustrate apparently coupled conformational motions that bridge the active
site, substrate binding pocket, inter-domain interface, and parts of the broad dimer interface (Fig. 5,
Fig. 6). This is particularly noteworthy since Mpro must dimerize to become an active enzyme (Fan et
al., 2004; Goyal & Goyal, 2020); inter-domain flexing has also been observed, even in crystals
(Jaskolski et al., 2021). The intramolecular network we describe includes several sites that are distal
from the active site, one of which is highlighted by unambiguous Glu240 difference density (Fig. 6c)
corresponding to a temperature-dependent rotamer flip—this site has already been characterized as
ligandable by recent crystallographic screens of pre-existing drug molecules (Günther et al., 2021)
and small-molecule fragments (Douangamath et al., 2020) (Fig. 6). Some new Mpro ligands have been
shown by mass spectrometry to disrupt the Mpro dimer and allosterically inhibit catalysis, albeit weakly
thus far (El-Baba et al., 2020), illustrating the potential of an allosteric strategy. As a complementary
structure-based approach to current experiments on the dimeric crystal form of Mpro, future
experiments could exploit mutations of the dimer interface to stabilize an inactive monomer, thus
capturing a new structural target for crystallographic and solution screening for allosteric inhibitors that
block dimerization. Ultimately, the present study offers insights into fundamental aspects of protein
structural biophysics, and may also help pave the way for new efforts toward allosteric modulation of
Mpro as a strategy for COVID-19 antiviral drug design.
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Methods
Cloning, expression, and purification
Full details of the cloning, expression, and purification will be reported elsewhere (B.A., D.K., M.R.F.,
S.M. et al., in preparation). Briefly, the codon-optimized synthetic gene of full-length Mpro from
SARS-CoV-2 was cloned into the pET29b vector. The cloned Mpro with C-terminal 6x histidine tag was
expressed in E. coli using an auto-induction procedure (Studier, 2005). Cells were harvested, lysed
using bacterial protein extraction agents (B-PER, ThermoFisher Scientific) in the presence of
lysozyme, and purified with nickel-affinity chromatography followed by size exclusion chromatography.
The histidine tag was cleaved by human rhinovirus (HRV) 3C protease (AcroBIOSYSTEMS) and
further purified by reverse nickel-affinity chromatography. The purified protein was then dialysed
overnight at 4°C against 30 mM HEPES pH 7.4, 200 mM NaCl, 1 mM TCEP; concentrated to ~7
mg/mL; and used for crystallization or stored at 80°C.

Crystallization
Plate-like crystals ranging from ~100–400 µm along the longest axis (~5–10 µm along the shortest
axis) were grown via sitting drop vapor diffusion. The crystals grew in flower-like clusters (Supp. Fig.
5). After mixing a 1:1 ratio of ~7 mg/mL M pro with a solution of 22% PEG 4000, 100 mM HEPES pH
7.0, 3–5% DMSO and incubating at a temperature of ~298 K, crystals were seen after 2–6 days.

Crystal harvesting and X-ray data collection
Individual crystals were harvested using 10 µm MicroMesh™ loops (MiTeGen). For cryogenic
temperature, crystals were cryocooled by the traditional practice of plunging into liquid nitrogen. For
non-cryogenic temperatures at ambient humidity, crystals were coated with paratone oil, then
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mounted on the goniometer for data collection. Datasets were also collected for crystals coated with
paratone oil and additionally enclosed in MicroRT™ capillaries (MiTeGen), but no differences were
observed relative to paratone oil only. For high humidity, crystals were not coated with paratone oil,
but were enclosed in MicroRT™ capillaries for the short transit to the goniometer, then removed once
humid air flow was established on the goniometer; this ensured the crystal was always maintained at
high humidity after leaving the crystallization drop. Each crystal was equilibrated on the goniometer for
10-20 minutes, more than sufficient to reach stable conditions.

X-ray data were collected at the National Synchrotron Light Source II (NSLS-II) beamline 17-ID-2
(FMX) (Schneider et al., 2021) using an X-ray beam of energy 12.66 keV, corresponding to a
wavelength of 0.9793 Å; a horizontal-bounce Si111 double crystal monochromator; and an Eiger X
16M pixel array detector (Dectris). Temperature at the sample goniometer was controlled using a
Cryostream 800 (OxfordCryosystems). For the 298 K, 99.5% relative humidity dataset, RH was
controlled with an HC-LAB Humidity Controller (Arinax). Ambient temperature was measured to be
~298 K, and ambient humidity was measured to be 36.7%. A new crystal was used for each dataset.
Helical/vector data collection was used to traverse the length of each crystal, with a beam size of 10 x
10 µm. Using RADDOSE-3D (Bury et al., 2018), we estimated diffraction-weighted dose (DWD) for
our datasets to be 242 kGy for 100 K, 532 kGy for 240 K, 397 kGy for 277 K, 137 kGy for 298 K, 182
kGy for 298 K (99.5% RH), and 176 kGy for 310 K. All of these DWD values are at or below the
estimated room-temperature limit of about 400 kGy (Fischer, 2021) for our higher temperatures,
although this limit is generally system-dependent. The DWD for 240 K is above the room-temperature
limit, but such lower temperatures have higher dose tolerance. Additionally, there was no evidence of
global radiation damage from Rd plots (Supp. Fig. 1), and local/specific radiation damage did not
appreciably accrue during the course of each single-crystal data collection, as indicated by 2Fo-Fc
electron density maps around carboxyl groups (not shown).
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X-ray data reduction and modeling
The data reduction pipeline fast_dp (Winter & McAuley, 2011) was initially used for bulk data reduction
during the beamtime, with selected data reprocessed using the xia2 DIALS (Winter et al., 2018) and
xia2 3dii (XDS and XSCALE) pipelines (Kabsch, 2010), with xia2 3dii (XDS and XSCALE) also used
for the generation of Rd statistics (Diederichs, 2006) (Supp. Fig. 1). Molecular replacement for each
dataset was performed via Phaser-MR from the Phenix software suite, using PDB ID 6YB7 as a
search model. Phenix AutoBuild (Terwilliger et al., 2008) was used for initial model building and
refinement, with subsequent iterative refinements performed using phenix.refine (Afonine et al., 2012)
and Coot (Emsley & Cowtan, 2004). After a few initial rounds of refinements, hydrogens were added
using phenix.ready_set (Reduce (Word et al., 1999) and eLBOW (Moriarty et al., 2009)). For
refinement of each dataset, X-ray/stereochemistry weight and X-ray/ADP weight were refined and
optimised. Geometric and protein statistics of the final models were evaluated via MolProbity (Chen et
al., 2010; Williams et al., 2018) and the JCSG-QC check server
(https://smb.slac.stanford.edu/jcsg/QC/). Data collection and refinement statistics are shown in Table
1.

Crystallographic ensemble models were generated using phenix.ensemble_refinement (Burnley et al.,
2012) in version 1.18.2-3874 of Phenix. Alternate conformations were first removed from the
multiconformer models, and hydrogens were (re)added using phenix.ready_set. Next, a
phenix.ensemble_refinement grid search was performed by repeating the simulation with four values
of pTLS (1.0, 0.9, 0.8, 0.6) and three values of wxray_coupled_tbath_offset (10, 5, 2.5), and using a
random_seed value of 2679941. τx was set automatically according to the high-resolution limit of the
dataset. From this grid, we present the analysis of the set of ensemble models that has both the
lowest mean Rfree and the lowest mean Rfree-Rwork gap: pTLS=1.0, wxray_coupled_tbath_offset=2.5.
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Conclusions drawn for the set of ensemble models with lowest Rfree per dataset, or the lowest
Rfree-Rwork gap per dataset, were similar. Refinement statistics are shown in Table 2.

For Fo-Fo isomorphous difference map analysis, the phenix.fobs_minus_fobs_map executable in the
Phenix software suite was used. Each elevated temperature was compared to 100 K. The 100 K
multiconformer model was used for phasing for each difference map. For solvent content analysis,
rwcontents v7.1.009 from the CCP4 suite (Winn et al., 2011) was used.

Accession numbers and data availability
Models and structure factors are available in the Protein Data Bank under the following PDB ID
accession codes (see also Table 1 and Table 2): 7MHF, 7MHG, 7MHH, 7MHI, 7MHJ, 7MHK for
muticonformer models, and 7MHL, 7MHM, 7MHN, 7MHO, 7MHP, 7MHQ for ensemble models.
Diffraction data are available at the Integrated Resource for Reproducibility in Macromolecular
Crystallography (https://proteindiffraction.org) under the following Digital Object Identifier names:
10.18430/m37mhf, 10.18430/m37mhg, 10.18430/m37mhh, 10.18430/m37mhi, 10.18430/m37mhj,
10.18430/m37mhk.

Glossary
Fo-Fo = isomorphous difference electron density map
COVID-19 = coronavirus disease 2019
SARS-CoV-2 = severe acute respiratory syndrome coronavirus 2
Mpro = SARS coronavirus main protease
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